Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts

Auteurs

Florence Coussy, Marion Lavigne, Leanne de Koning, Rania El Botty, Fariba Nemati, Adnan Naguez, Guillaume Bataillon, Berengère Ouine, Ahmed Dahmani, Elodie Montaudon, Pierre Painsec, Sophie Chateau-Joubert, Fuhrmann Laetitia, Thibaut Larcher, Sophie Vacher, Walid Chemlali, Adrien Briaux, Samia Melaabi, Anne Vincent Salomon, Jean Marc Guinebretiere, Ivan Bieche, Elisabetta Marangoni